PE Tech Report


Like this article?

Sign up to our free newsletter

Baird Capital invests in Prescient Healthcare Group

Baird Capital, the direct investment arm of Robert W Baird & Co, has acquired an interest in Prescient Healthcare Group (Prescient), a product strategy consultancy to the global biopharmaceutical industry.

As part of the transaction, Baird Capital Partner Andrew Ferguson and Principal John DiGiovanni will join the Prescient board of directors. Nick Edwards, founder and former Chairman of Kinapse, will chair the board.
Founded in 2007, Prescient is headquartered in London and has offices in the US, India and China. The business provides product strategy services to help its clients make better clinical and commercial decisions, resulting in enhanced outcomes for patients, customers and shareholders. Prescient partners with many of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech and specialty pharma organisations. 
“The Prescient team has built a fantastic business that day-in and day-out supports blue-chip clients with the insight and analysis they need to make business-critical decisions. Prescient’s commitment to delivering a top-quality service has resulted in a loyal and fast-growing customer base. The market for the company’s services is set to continue to grow strongly as biopharmaceutical companies seek to develop and market products in a cost- and time-effective way. Our investment and global resources will help further accelerate Prescient’s growth and we look forward to partnering with the team in an exciting future for the business,” says Andrew Ferguson, Partner at Baird Capital.
Jamie Denison-Pender, Prescient CEO, says: “We are thrilled to be partnering with Baird Capital, which has an extensive track record of helping people-based businesses grow and knowledge of the healthcare sector. Baird’s global resources, experience in scaling professional services organisations and focus on talent development will be critical as Prescient enters its next stage of growth. Prescient has an incredibly loyal customer base and this deal will enable us to continue enhancing the level and value of service we offer our clients.”

Like this article? Sign up to our free newsletter